Gaush Meditech Ltd. (HK:2407)
:2407
Want to see HK:2407 full AI Analyst Report?
Total Valuation
Gaush Meditech Ltd. has a market cap or net worth of HK$774.93M. The enterprise value is HK$738.76M.
Market CapHK$774.93M
Enterprise ValueHK$738.76M
Share Statistics
Gaush Meditech Ltd. has 147,887,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,887,860
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gaush Meditech Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.16%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.16%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.56M
Profits Per Employee129.73K
Employee Count884
Asset Turnover0.53
Inventory Turnover2.16
Valuation Ratios
The current PE Ratio of Gaush Meditech Ltd. is 11.2. Gaush Meditech Ltd.’s PEG ratio is 2.34.
PE Ratio11.2
PS Ratio0.78
PB Ratio0.64
Price to Fair Value0.64
Price to FCF9.72
Price to Operating Cash Flow4.84
PEG Ratio2.34
Income Statement
In the last 12 months, Gaush Meditech Ltd. had revenue of 1.38B and earned 96.19M in profits. Earnings per share was 0.66.
Revenue1.38B
Gross Profit633.20M
Operating Income121.65M
Pretax Income114.68M
Net Income96.19M
EBITDA169.71M
Earnings Per Share (EPS)0.66
Cash Flow
In the last 12 months, operating cash flow was 135.22M and capital expenditures -22.75M, giving a free cash flow of 112.47M billion.
Operating Cash Flow135.22M
Free Cash Flow112.47M
Free Cash Flow per Share0.76
Dividends & Yields
Gaush Meditech Ltd. pays an annual dividend of HK$0.3, resulting in a dividend yield of 3.48%
Dividend Per ShareHK$0.3
Dividend Yield3.48%
Payout Ratio39.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change-8.87%
50-Day Moving Average5.28
200-Day Moving Average7.44
Relative Strength Index (RSI)51.75
Average Volume (3m)147.22K
Important Dates
Gaush Meditech Ltd. upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).
Last Earnings DateMar 26, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Gaush Meditech Ltd. as a current ratio of 2.40, with Debt / Equity ratio of 30.05%
Current Ratio2.40
Quick Ratio1.63
Debt to Market Cap0.43
Net Debt to EBITDA0.39
Interest Coverage Ratio6.21
Taxes
In the past 12 months, Gaush Meditech Ltd. has paid 23.49M in taxes.
Income Tax23.49M
Effective Tax Rate0.20
Enterprise Valuation
Gaush Meditech Ltd. EV to EBITDA ratio is 6.72, with an EV/FCF ratio of 10.32.
EV to Sales0.83
EV to EBITDA6.72
EV to Free Cash Flow10.32
EV to Operating Cash Flow7.91
Balance Sheet
Gaush Meditech Ltd. has HK$440.94M in cash and marketable securities with HK$507.37M in debt, giving a net cash position of -HK$66.43M billion.
Cash & Marketable SecuritiesHK$440.94M
Total DebtHK$507.37M
Net Cash-HK$66.43M
Net Cash Per Share-HK$0.45
Tangible Book Value Per ShareHK$2.91
Margins
Gross margin is 45.87%, with operating margin of 8.81%, and net profit margin of 6.97%.
Gross Margin45.87%
Operating Margin8.81%
Pretax Margin8.31%
Net Profit Margin6.97%
EBITDA Margin12.29%
EBIT Margin8.16%
Analyst Forecast
The average price target for Gaush Meditech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.30%
EPS Growth Forecast6.27%